Sarah Boyce

Ms. Sarah Boyce is a Chairman at Atrium Therapeutics, Inc., an Independent Director at Contineum Therapeutics, Inc. and an Independent Director at OmniAb Operations, Inc. She is on the Board of Directors at Abcuro, Inc., Contineum Therapeutics, Inc. and OmniAb Operations, Inc. Ms. Boyce was previously employed as an Independent Director by OmniAb, Inc., an Independent Director by Ligand Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Avidity Biosciences, Inc., an Independent Director by Berkeley Lights, Inc., a President & Director by Akcea Therapeutics, Inc., a Chief Business Officer by Ionis Pharmaceuticals, Inc., a Vice President & Head-Business Strategy by Forest Laboratories, Inc., a VP & Global Head-Nephrology Therapeutics by Alexion Pharmaceuticals, Inc., and a Vice President-Global Program by Novartis AG.
She received her undergraduate degree from The University of Manchester.